Adenoviral Vectors for Gene Therapy

— —

David T. Curiel (Washington University School of Medicine, St. Louis, MO, USA) Alan L. Parker, PhD (Professor of Translational Virotherapies, Head of Section of Solid Cancers, Division of Cancer and Genetics, University of Cardiff, UK)

Adenoviral Vectors for Gene Therapy

David T. Curiel (Washington University School of Medicine, St. Louis, MO, USA), Alan L. Parker, PhD (Professor of Translational Virotherapies, Head of Section of Solid Cancers, Division of Cancer and Genetics, University of Cardiff, UK)

$436.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
25 April 2025

Medical genetics; Therapy & therapeutics

Adenoviral Vectors for Gene Therapy, Third Edition, provides detailed, comprehensive coverage of gene delivery vehicles based on the adenovirus that is emerging as an important tool in gene therapy. These exciting new therapeutic agents have great potential for the treatment of disease, as platforms for gene therapy and gene editing, as well as for oncology approaches, making them class leading agents in the gene-advanced therapies arena.

The fully updated and expanded third edition covers the basic biology of adenoviruses and highlights the potential use of adenoviral vectors for the treatment of disease, including their construction, propagation, and purification, cutting-edge vectorology, and the use of adenoviral vectors in preclinical animal models. The book also considers the regulatory issues surrounding human clinical gene therapy trials. New chapters include adenoviral vaccines for veterinary applications, adenoviruses for gene editing, nonhuman primate adenoviruses, COVID-19 vaccines, vaccine applications, and oncolytic adenoviruses for antitumor immunization. This broad scope of information provides a solid overview of the field, allowing the reader to gain a complete understanding of the development and use of adenoviral vectors.

Edited by: David T. Curiel (Washington University School of Medicine St. Louis MO USA), Alan L. Parker, PhD (Professor of Translational Virotherapies, Head of Section of Solid Cancers, Division of Cancer and Genetics, University of Cardiff, UK)
Imprint: Academic Press Inc
Country of Publication: United Kingdom
Edition: 3rd edition
Dimensions: Height: 235mm, Width: 191mm,
Weight: 450g
ISBN: 9780323898218
ISBN 10: 0323898211
Pages: 906
Publication Date: 25 April 2025
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

David T. Curiel, M.D., Ph.D. is the Director of the Cancer Biology Division of the Department of Radiation Oncology at Washington University School of Medicine. Dr. Curiel graduated medical school at Emory University in 1982, where he also completed his internship and residency in Internal Medicine. Dr. Curiel’s scientific training includes tenureship at the National Institutes of Health in Bethesda, Maryland at the Pulmonary Branch of the Heart and Lung, and Blood Institute (NHLBI) from 1985-1989, and a fellowship in Biotechnology at the National Cancer Institute, Navy Medical Oncology Branch from 1989-1990. He received his Ph.D. from University of Groningen in The Netherlands in 2002. Dr. Curiel has been at Washington University School of Medicine since 2011. In addition to his role as Director of the Cancer Biology Division, he is Director of the Biologic Therapeutics Center.

MOTHER'S DAY SPECIALS! SHOW ME MORE

Adenoviral Vectors for Gene Therapy

David T. Curiel (Washington University School of Medicine, St. Louis, MO, USA), Alan L. Parker, PhD (Professor of Translational Virotherapies, Head of Section of Solid Cancers, Division of Cancer and Genetics, University of Cardiff, UK)

$436.95

Hardback

See Also

Contact Abbeys

Contact Galaxy

Contact Language

Contact Us

About ABBEY'S